Document is current
Any future updates will be listed below
-
Authors
Jeong, Tae-Kyeong
Frater, R. Ciaran MacKenzie https://orcid.org/0009-0002-4701-6598
Yoon, Jongha
Groth, Anja https://orcid.org/0000-0003-0577-1771
Song, Ji-Joon https://orcid.org/0000-0001-7120-6311
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (RS-2023-00266300, RS-2024-00440614)
Novo Nordisk Fonden (NNF21OC0067425, NNF14CC0001)
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 6 February 2025
First Online: 4 March 2025
Competing interests
: J.S. is a CTO of Epinogen. A.G. is a co-founder and CSO of Ankrin Therapeutics. All remaining authors declare no competing interests.
